Douglas A Levine MD
Douglas A Levine MD
NYU Langone Health
Verified email at nyumc.org
Title
Cited by
Cited by
Year
Integrated genomic characterization of endometrial carcinoma
DA Levine, Cancer Genome Atlas Research Network
Nature 497 (7447), 67-73, 2013
23762013
Absolute quantification of somatic DNA alterations in human cancer
SL Carter, K Cibulskis, E Helman, A McKenna, H Shen, T Zack, PW Laird, ...
Nature biotechnology 30 (5), 413-421, 2012
11422012
Rethinking ovarian cancer: recommendations for improving outcomes
S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ...
Nature Reviews Cancer 11 (10), 719-725, 2011
10422011
Inferring tumour purity and stromal and immune cell admixture from expression data
K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ...
Nature communications 4 (1), 1-11, 2013
9632013
Evaluating cell lines as tumour models by comparison of genomic profiles
S Domcke, R Sinha, DA Levine, C Sander, N Schultz
Nature communications 4 (1), 1-10, 2013
8732013
Resistance to therapy caused by intragenic deletion in BRCA2
SL Edwards, R Brough, CJ Lord, R Natrajan, R Vatcheva, DA Levine, ...
Nature 451 (7182), 1111-1115, 2008
7932008
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
7592018
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
6562018
Network modeling links breast cancer susceptibility and centrosome dysfunction
MA Pujana, JDJ Han, LM Starita, KN Stevens, M Tewari, JS Ahn, ...
Nature genetics 39 (11), 1338-1349, 2007
6372007
What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
DS Chi, EL Eisenhauer, J Lang, J Huh, L Haddad, NR Abu-Rustum, ...
Gynecologic oncology 103 (2), 559-564, 2006
5692006
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
5422018
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ...
Nature reviews Cancer 15 (11), 668-679, 2015
5382015
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
4982013
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm
DS Chi, EL Eisenhauer, O Zivanovic, Y Sonoda, NR Abu-Rustum, ...
Gynecologic oncology 114 (1), 26-31, 2009
4922009
Frequent mutation of the PIK3CA gene in ovarian and breast cancers
DA Levine, F Bogomolniy, CJ Yee, A Lash, RR Barakat, PI Borgen, J Boyd
Clinical cancer research 11 (8), 2875-2878, 2005
4802005
Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer
KL Bolton, G Chenevix-Trench, C Goh, S Sadetzki, SJ Ramus, BY Karlan, ...
Jama 307 (4), 382-389, 2012
4782012
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
4702018
OncoKB: a precision oncology knowledge base
D Chakravarty, J Gao, S Phillips, R Kundra, H Zhang, J Wang, ...
JCO precision oncology 1, 1-16, 2017
4622017
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
4412018
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
RGW Verhaak, P Tamayo, JY Yang, D Hubbard, H Zhang, CJ Creighton, ...
The Journal of clinical investigation 123 (1), 2012
4312012
The system can't perform the operation now. Try again later.
Articles 1–20